Literature DB >> 16621115

Prognostic significance of the white coat hypertension in patients with type 1 diabetes mellitus.

Lilliam Flores1, Margarita Giménez, Enric Esmatjes.   

Abstract

Despite the high prevalence of white coat hypertension (WCH) in diabetes mellitus and the evidence that hypertension is a clear risk factor for the development of microalbuminuria (MA) in these patients, there is no information on the long-term prognostic significance of this condition in the diabetic population. We studied the evolution of 40 patients with type 1 diabetes mellitus (Type 1 DM). Twenty patients with WCH (office blood pressure> or =140/90mmHg associated with mean daytime blood pressure<135/85mmHg) classified as the WCH group and 20 patients with type 1 DM with a similar age and disease evolution, but who were normotensive, (office blood pressure<140/90mmHg associated with mean daytime blood pressure<135/85mmHg) classified as the normotensive control group. After 5 years of follow-up, MA appeared in four subjects and sustained hypertension in another, with a total of 31% of events in the WCH group, with none in the normotensive group. Kaplan-Meier analysis showed that the relative risk of developing these hypertensive events was 25% higher in the WCH group. At baseline, the night time systolic and diastolic blood pressure levels were significantly higher in patients who further developed MA and sustained hypertension. The findings in this study highlight the clinical importance of careful follow-up of type 1 diabetic patients with WCH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621115     DOI: 10.1016/j.diabres.2006.03.006

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

1.  Masked hypertension in diabetes mellitus: a potential risk.

Authors:  Kazuo Eguchi; Joji Ishikawa; Satoshi Hoshide; Thomas G Pickering; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-08       Impact factor: 3.738

Review 2.  White-coat hypertension should not be treated in subjects with diabetes.

Authors:  Michael Bursztyn; Iddo Z Ben-Dov
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

Review 3.  Should white-coat hypertension in diabetes be treated? Pro.

Authors:  Giuseppe Mancia; Roberto Sega; Michele Bombelli; Fosca Quarti-Trevano; Rita Facchetti; Guido Grassi
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

4.  Impact of white-coat hypertension on microvascular complications in type 2 diabetes.

Authors:  Caroline K Kramer; Cristiane B Leitão; Luís H Canani; Jorge L Gross
Journal:  Diabetes Care       Date:  2008-09-03       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.